INSIGHTS ON PHARMACEUTICAL LOGISTICS

• Cryogenic Storage Of IV Bags For Cell And Gene Therapies

  Cryogenic storage can compromise packaging integrity for cell and gene therapies. Learn how vacuum decay technology detects micro leaks and ensures product safety under extreme conditions.

• Moving Batch Release Into The Fast Lane

  Complex supply chains and fragmented systems slow batch release, delaying patient access and revenue goals. Learn how automation and centralized data improve compliance and accelerate delivery.

• Shedding Light On Photo-Stability Forced Degradation

  Ensure the stability and safety of your drug products by utilizing comprehensive forced degradation and photo-stability testing, guided by ICH and FDA standards, to identify degradation pathways and assess light exposure risks.

• Addressing The Acetonitrile Supply By Implementing Strategies

  Rising acetonitrile demand threatens supply chains; recovery and reuse methods using evaporation and crystallization produce high‑purity solvent, reducing costs, waste, and reliance on fresh supply.

• Global Strategies For Resilience And Redundancy In Cell Culture Media Supply

  7/17/2025

  Ensure your cell culture media supply remains uninterrupted. Explore proactive strategies for global manufacturing equivalency and consistent media delivery.

• A Temperature-Stable Replacement For Animal Trypsin In Cell Dissociation Applications

  6/9/2025

  Improve cell dissociation with a gentle, recombinant enzyme. This temperature-stable protease shows dissociation kinetics similar to porcine trypsin but with lower cell toxicity and greater overall purity.

• The Future Of RNA Manufacturing Starts With Raw Material Innovation

  2/11/2026

  Amid the mRNA and oligonucleotide therapeutic boom, sponsors and manufacturers are exploring how to make critical raw materials—capping agents, lipid nanoparticles, and RNA polymerase—more effective.

• Demonstrating Technical Excellence In Contract Manufacturing

  12/10/2024

  Tech Talks explore ADC development innovations, including integrated supply chains, seamless pilot-to-GMP scale-ups, and advanced process analytical technology (PAT).

• Strengthen Pharmaceutical Supply Chains With A U.S.-Based CDMO

  6/5/2025

  While certain ingredients require sourcing abroad, partnering with a U.S.-based company that owns its manufacturing assets allows for direct oversight of product quality and supply reliability.